According to Matinas BioPharma's latest financial reports the company's total debt is A$4.83 Million. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | A$6.06 M | -6.58% |
2021-12-31 | A$6.48 M | 33.01% |
2020-12-31 | A$4.87 M | -19.25% |
2019-12-31 | A$6.03 M | 988.86% |
2018-12-31 | A$0.55 M | 63.47% |
2017-12-31 | A$0.33 M | 69.34% |
2016-12-31 | A$0.2 M | 1196.19% |
2015-12-31 | A$0.01 M | -78.79% |
2014-12-31 | A$0.07 M | |
2013-12-31 | N/A |